MedTrace Logo

The Relationship Between Clotting Factor VIII and Bleeding Adverse Reactions in Patients Under the Therapies of Thrombolysis, Anticoagulation and Anti-platelet

NCT02677818 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-04-04

No results posted yet for this study

Summary

The purpose of this study is to determine whether Plasma Factor VIII Levels are related to the treatment of bleeding in ischemic stroke（IS）.

Conditions

Sponsors & Collaborators

  • Guangdong Province, Department of Science and Technology

    collaborator OTHER_GOV

  • Zhujiang Hospital

    lead OTHER

Principal Investigators

  • Yong Wang, Doctor · clinical drug trial institution

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2018-01-31
Completion
2021-08-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02677818 on ClinicalTrials.gov